The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new ...
People often believe pursuing a degree from reputed universities and colleges can make them better candidates in the job ...
From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.
Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...
A Cambridge PhD, Marika Niihori, faced a tough job market, receiving over 70 rejections. Despite her prestigious degree, she ...
Regional Centre for Biotechnology (RCB), Faridabad, Haryana-121001, has invited applications for admission to the MS-PhD ...
Biopharmaceutical company recognized for innovation in the development of immune-modulatory therapeutic cancer vaccines –NEW YORK, March 18, ...
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck CancerConference call and webcast today ...
Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision ...
Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback